Ron Milo

4.7k total citations · 2 hit papers
66 papers, 3.3k citations indexed

About

Ron Milo is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Ron Milo has authored 66 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pathology and Forensic Medicine, 19 papers in Immunology and 14 papers in Molecular Biology. Recurrent topics in Ron Milo's work include Multiple Sclerosis Research Studies (27 papers), Immunotherapy and Immune Responses (13 papers) and T-cell and B-cell Immunology (9 papers). Ron Milo is often cited by papers focused on Multiple Sclerosis Research Studies (27 papers), Immunotherapy and Immune Responses (13 papers) and T-cell and B-cell Immunology (9 papers). Ron Milo collaborates with scholars based in Israel, United States and Germany. Ron Milo's co-authors include Esther Kahana, Abraham Kandel, M. Friedman, Ariel Miller, Nicole Kerlero de Rosbo, Avraham Ben‐Nun, Danielle Burger, Claude C.A. Bernard, Marjorie B. Lees and Hillel Panitch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ron Milo

65 papers receiving 3.2k citations

Hit Papers

Complex fuzzy sets 2002 2026 2010 2018 2002 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Milo Israel 26 1.2k 892 619 445 413 66 3.3k
Rong Yang United States 34 167 0.1× 1.8k 2.0× 123 0.2× 73 0.2× 1.7k 4.2× 79 7.2k
Jan Komorowski Poland 38 304 0.3× 449 0.5× 61 0.1× 125 0.3× 4.2k 10.2× 224 6.9k
Ping Zeng China 31 97 0.1× 142 0.2× 89 0.1× 183 0.4× 984 2.4× 168 3.2k
Werner Brannath Austria 35 190 0.2× 225 0.3× 1.1k 1.7× 143 0.3× 334 0.8× 119 3.7k
Jiang Gui United States 35 240 0.2× 472 0.5× 26 0.0× 116 0.3× 1.1k 2.8× 156 3.8k
Johan Björkegren Sweden 40 155 0.1× 1.3k 1.4× 39 0.1× 80 0.2× 3.2k 7.8× 112 7.0k
Masao Nagasaki Japan 35 185 0.2× 1.3k 1.4× 41 0.1× 35 0.1× 2.6k 6.3× 191 6.0k
Frank C. Kuo United States 37 790 0.7× 1.6k 1.8× 57 0.1× 113 0.3× 5.2k 12.6× 86 12.1k
Qin Yu China 24 71 0.1× 131 0.1× 162 0.3× 92 0.2× 1.2k 2.8× 76 2.2k
Reza Forghani Canada 36 221 0.2× 612 0.7× 8 0.0× 301 0.7× 478 1.2× 110 4.4k

Countries citing papers authored by Ron Milo

Since Specialization
Citations

This map shows the geographic impact of Ron Milo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Milo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Milo more than expected).

Fields of papers citing papers by Ron Milo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Milo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Milo. The network helps show where Ron Milo may publish in the future.

Co-authorship network of co-authors of Ron Milo

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Milo. A scholar is included among the top collaborators of Ron Milo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Milo. Ron Milo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrou, Panayiota, Anat Achiron, David Magalashvili, et al.. (2023). Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint. Journal of Neurology. 270(11). 5188–5195. 3 indexed citations
2.
Milo, Ron, Oren S. Cohen, Joab Chapman, et al.. (2022). Genetic Creutzfeldt‐Jakob disease in Turkish Jews—demographic and clinical features. Acta Neurologica Scandinavica. 146(5). 586–589. 1 indexed citations
3.
Boyко, Alexey, Dana Horáková, Jarmila Szilasiová, et al.. (2021). Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. Multiple Sclerosis and Related Disorders. 50. 102778–102778. 9 indexed citations
4.
Radomir, Lihi, Matthias P. Kramer, Nofar Schottlender, et al.. (2021). The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5. Nature Communications. 12(1). 1893–1893. 49 indexed citations
5.
Menascu, Shay, Aviva Fattal‐Valevski, Adi Vaknin‐Dembinsky, et al.. (2021). Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage. Journal of the Neurological Sciences. 432. 120074–120074. 6 indexed citations
6.
Zuckerman, Neta S., Victoria Indenbaum, Ron Milo, Ella Mendelson, & Yaniv Lustig. (2019). JC virus identified in a patient with persistent and severe West Nile virus disease. Journal of NeuroVirology. 25(4). 608–611. 2 indexed citations
9.
Milo, Ron & Olaf Stüve. (2016). Spotlight on daclizumab: its potential in the treatment of multiple sclerosis. PubMed. Volume 6. 95–109. 2 indexed citations
10.
Wijmeersch, Bart Van, Celia Oreja‐Guevara, & Ron Milo. (2015). Can We Offer More to Patients with Multiple Sclerosis?. European Neurological Review. 10(2). 139–139. 1 indexed citations
11.
Inzelberg, Rivka, J. M. Rabey, E. Melamed, et al.. (2011). High prevalence of malignant melanoma in Israeli patients with Parkinson’s disease. Journal of Neural Transmission. 118(8). 1199–1207. 23 indexed citations
12.
Sellner, Johann, Jörg Kraus, Amer Awad, et al.. (2011). The increasing incidence and prevalence of female multiple sclerosis—A critical analysis of potential environmental factors. Autoimmunity Reviews. 10(8). 495–502. 158 indexed citations
13.
Milo, Ron & Hillel Panitch. (2010). Combination therapy in multiple sclerosis. Journal of Neuroimmunology. 231(1-2). 23–31. 24 indexed citations
14.
Milo, Ron & Esther Kahana. (2009). Multiple sclerosis: Geoepidemiology, genetics and the environment. Autoimmunity Reviews. 9(5). A387–A394. 481 indexed citations breakdown →
15.
16.
Milo, Ron, et al.. (2001). On fuzzy correlations. IEEE Transactions on Systems Man and Cybernetics Part B (Cybernetics). 31(3). 381–390. 9 indexed citations
17.
Rosbo, Nicole Kerlero de, Ron Milo, Marjorie B. Lees, et al.. (1993). Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.. Journal of Clinical Investigation. 92(6). 2602–2608. 271 indexed citations
18.
Outryve, M. Van, et al.. (1991). “Prokinetic” Treatment of Constipation-Predominant Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 13(1). 49–57. 83 indexed citations
19.
Milo, Ron, et al.. (1988). Descending perineum syndrome: control defecogram with a "perineum device", perspective in prevention and conservative therapy.. PubMed. 71(6). 709–12. 4 indexed citations
20.
Milo, Ron, N. Razon, & J. Schiffer. (1987). Delayed epidural hematoma a review. Acta Neurochirurgica. 84(1-2). 13–23. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026